These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29792151)

  • 21. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
    Bhatt JD; Chudasama CJ; Patel KD
    Bioorg Med Chem; 2015 Dec; 23(24):7711-6. PubMed ID: 26631439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HTS, chemical hybridization, and drug design identify a chemically unique antituberculosis agent-coupling serendipity and rational approaches to drug discovery.
    Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    ChemMedChem; 2007 Jun; 2(6):811-3. PubMed ID: 17455191
    [No Abstract]   [Full Text] [Related]  

  • 25. Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
    Walter I; Adam S; Gentilini MV; Kany AM; Brengel C; Thomann A; Sparwasser T; Köhnke J; Hartmann RW
    ChemMedChem; 2021 Sep; 16(18):2786-2801. PubMed ID: 34010508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
    Shelke SN; Mhaske GR; Bonifácio VD; Gawande MB
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5727-30. PubMed ID: 22832312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives.
    Foroumadi A; Asadipour A; Mirzaei M; Karimi J; Emami S
    Farmaco; 2002 Sep; 57(9):765-9. PubMed ID: 12385528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
    Kumar G; Siva Krishna V; Sriram D; Jachak SM
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
    Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
    Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
    Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
    Alegaon SG; Alagawadi KR; Sonkusare PV; Chaudhary SM; Dadwe DH; Shah AS
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1917-21. PubMed ID: 22325950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
    Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
    Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.
    Pradeep Kumar CB; Prathibha BS; Prasad KNN; Raghu MS; Prashanth MK; Jayanna BK; Alharthi FA; Chandrasekhar S; Revanasiddappa HD; Yogesh Kumar K
    Bioorg Med Chem Lett; 2021 Mar; 36():127810. PubMed ID: 33482292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antitubercular screening of imidazole derivatives.
    Pandey J; Tiwari VK; Verma SS; Chaturvedi V; Bhatnagar S; Sinha S; Gaikwad AN; Tripathi RP
    Eur J Med Chem; 2009 Aug; 44(8):3350-5. PubMed ID: 19272678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
    Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and some reactions of 1-methyl-1H-2-cyanomethyl-imidazo[4,5-b]pyridine. Tuberculostatic activity of obtained compounds.
    Bukowski L; Janowiec M
    Pharmazie; 1990 Dec; 45(12):904-7. PubMed ID: 2129248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2-b]pyrazole-7-carboxamides.
    Demjén A; Alföldi R; Angyal A; Gyuris M; Hackler L; Szebeni GJ; Wölfling J; Puskás LG; Kanizsai I
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800062. PubMed ID: 29888449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis.
    Early JV; Casey A; Martinez-Grau MA; Gonzalez Valcarcel IC; Vieth M; Ollinger J; Bailey MA; Alling T; Files M; Ovechkina Y; Parish T
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3608-16. PubMed ID: 27044545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.